Li Nan

1.7k total citations
44 papers, 1.1k citations indexed

About

Li Nan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Li Nan has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Oncology and 16 papers in Genetics. Recurrent topics in Li Nan's work include Virus-based gene therapy research (11 papers), Herpesvirus Infections and Treatments (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Li Nan is often cited by papers focused on Virus-based gene therapy research (11 papers), Herpesvirus Infections and Treatments (7 papers) and Multiple Myeloma Research and Treatments (5 papers). Li Nan collaborates with scholars based in United States, China and Egypt. Li Nan's co-authors include Sudhir Agrawal, Ruiwen Zhang, Adam B. Keeton, Gary A. Piazza, Dong Soo Yu, Bernard D. Gary, Elizabeth A. Beierle, Huamiao Wang, James M. Markert and Gregory K. Friedman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Li Nan

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Nan United States 19 566 375 300 166 132 44 1.1k
Arun Kumar Trivedi India 24 940 1.7× 327 0.9× 126 0.4× 162 1.0× 141 1.1× 70 1.5k
Sabine M. Klauck Germany 20 955 1.7× 171 0.5× 155 0.5× 137 0.8× 160 1.2× 58 1.6k
Xianping Lu China 21 1.2k 2.1× 505 1.3× 142 0.5× 205 1.2× 86 0.7× 44 1.7k
Adel Kardosh United States 19 424 0.7× 419 1.1× 109 0.4× 165 1.0× 225 1.7× 75 1.4k
Ashwini L. Chand Australia 22 753 1.3× 566 1.5× 314 1.0× 329 2.0× 52 0.4× 41 1.6k
Li Lai United States 18 721 1.3× 217 0.6× 169 0.6× 98 0.6× 64 0.5× 43 1.2k
M Oshimura Japan 9 945 1.7× 265 0.7× 126 0.4× 92 0.6× 68 0.5× 11 1.4k
Christoforos Thomas United States 18 665 1.2× 474 1.3× 491 1.6× 84 0.5× 53 0.4× 30 1.3k
Chao‐Wen Cheng Taiwan 22 578 1.0× 249 0.7× 83 0.3× 396 2.4× 143 1.1× 65 1.4k

Countries citing papers authored by Li Nan

Since Specialization
Citations

This map shows the geographic impact of Li Nan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Nan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Nan more than expected).

Fields of papers citing papers by Li Nan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Nan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Nan. The network helps show where Li Nan may publish in the future.

Co-authorship network of co-authors of Li Nan

This figure shows the co-authorship network connecting the top 25 collaborators of Li Nan. A scholar is included among the top collaborators of Li Nan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Nan. Li Nan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Hua, Lu Xu, Li Nan, et al.. (2025). Role of senescent CD4+ T cells in breakthrough infection of the new variant strain of SARS-CoV-2 in elderly patients. Journal of Translational Medicine. 23(1). 737–737. 1 indexed citations
2.
Zhang, Duo, et al.. (2025). Progress in the molecular epidemiology of chikungunya virus. 1(2). 164–169. 1 indexed citations
3.
4.
Li, Yiquan, Shanzhi Li, Yilong Zhu, et al.. (2023). Human adenovirus type 7 virus-like particle vaccine induces Dendritic cell maturation through the TLR4/NF-κB pathway and is highly immunogenic. Antiviral Research. 212. 105559–105559. 1 indexed citations
5.
Tinsley, Heather N., Bini Mathew, Yulia Maxuitenko, et al.. (2023). Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats. Cancers. 15(3). 646–646. 5 indexed citations
6.
Kang, Kyung‐Don, Joshua D. Bernstock, Stacie K. Totsch, et al.. (2022). Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers. Clinical Cancer Research. 28(24). 5419–5430. 11 indexed citations
7.
Liu, Songrui, Pei Huang, Zengguo Cao, et al.. (2022). Feline Panleukopenia Virus With G299E Substitution in the VP2 Protein First Identified From a Captive Giant Panda in China. Frontiers in Cellular and Infection Microbiology. 11. 820144–820144. 18 indexed citations
8.
Liu, Yuanyuan, Liang Ma, Yongwei Jiang, et al.. (2019). Relationship between insertion/deletion polymorphism of angiotensin converting enzyme gene and type 2 diabetic kidney disease. Zhonghua jianyan yixue zazhi. 42(2). 116–122. 2 indexed citations
9.
10.
Aye, Jamie M., Venkatram R. Atigadda, Blake P. Moore, et al.. (2018). UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts. Journal of Neuro-Oncology. 140(2). 209–224. 11 indexed citations
11.
Friedman, Gregory K., Joshua D. Bernstock, Dongquan Chen, et al.. (2018). Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression. Scientific Reports. 8(1). 13930–13930. 59 indexed citations
12.
Li, Rong, Blake P. Moore, Li Nan, et al.. (2017). Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002. Molecular Therapy — Oncolytics. 7. 27–36. 18 indexed citations
13.
Zhao, Xin, Li Nan, Yiming Ren, et al.. (2016). Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLoS ONE. 11(8). e0160500–e0160500. 13 indexed citations
14.
Aboul‐Fadl, Tarek, Kevin Lee, Li Nan, et al.. (2014). Novel non-cyclooxygenase inhibitory derivatives of naproxen for colorectal cancer chemoprevention. Medicinal Chemistry Research. 23(9). 4177–4188. 20 indexed citations
15.
Friedman, Gregory K., Li Nan, V. Kelly, et al.. (2014). γ134.5-deleted HSV-1-expressing human cytomegalovirus IRS1 gene kills human glioblastoma cells as efficiently as wild-type HSV-1 in normoxia or hypoxia. Gene Therapy. 22(4). 348–355. 29 indexed citations
16.
Ruan, Jian, Timothy N. Trotter, Li Nan, et al.. (2013). Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease. Bone. 57(1). 10–17. 38 indexed citations
17.
Yang, Yang, Yongsheng Ren, Vishnu C. Ramani, et al.. (2010). Heparanase Enhances Local and Systemic Osteolysis in Multiple Myeloma by Upregulating the Expression and Secretion of RANKL. Cancer Research. 70(21). 8329–8338. 56 indexed citations
18.
Caicedo, Ricardo A., Li Nan, Clotilde Des Robert, et al.. (2008). Neonatal Formula Feeding Leads to Immunological Alterations in an Animal Model of Type 1 Diabetes. Pediatric Research. 63(3). 303–307. 10 indexed citations
19.
Wang, Zhi, Hui Wang, Julie K. Rhie, et al.. (2006). Determination of desoxyepothilone B in nude mice plasma by liquid–liquid extraction and reversed-phase high-performance liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis. 42(2). 272–276. 7 indexed citations
20.
Kawamata, Hitoshi, Morio Azuma, Shuji Kameyama, Li Nan, & Ryoichi Oyasu. (1992). Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.. PubMed. 3(11). 819–25. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arun Kumar Trivedi Breakdown of academic impact, for papers by Sabine M. Klauck Breakdown of academic impact, for papers by Xianping Lu Breakdown of academic impact, for papers by Adel Kardosh Breakdown of academic impact, for papers by Ashwini L. Chand Breakdown of academic impact, for papers by Li Lai Breakdown of academic impact, for papers by M Oshimura Breakdown of academic impact, for papers by Christoforos Thomas Breakdown of academic impact, for papers by Chao‐Wen Cheng
Rankless by CCL
2026